HRT for Men

Testosterone Therapy in 2026: What the FDA's Label Changes Mean for Men Over 40

By Andrologix Clinical Team4 min read
Blank prescription carton, clinical report folder and blue clipboard on a bright desk beside an ocean-view window

Quick answer

In February 2025 the FDA removed cardiovascular risk language from the boxed warning on all testosterone products after the TRAVERSE trial of 5,246 men. In June 2026, HHS asked the FDA to also remove label language saying TRT's safety and effectiveness were not established for age-related low testosterone. TRT remains a prescription therapy that starts with labs and a physician evaluation.

For years, men who asked about testosterone replacement therapy (TRT) heard the same two warnings: it might raise heart attack and stroke risk, and it was not proven for low testosterone that comes with age. Both of those messages are now changing on the official label. If you are in your 40s, 50s or 60s and have been putting off a conversation about low testosterone, this is a good time to understand what is new and what still matters.

What the FDA changed in 2025, and why TRAVERSE mattered

In February 2025 the FDA announced class-wide labeling changes for every testosterone product sold in the United States. The biggest change: language about increased risk of major adverse cardiovascular events was removed from the boxed warning.

That decision rested on the TRAVERSE trial, the largest randomized study of testosterone and heart safety ever run. TRAVERSE enrolled 5,246 men aged 45 to 80 who had low testosterone along with existing heart disease or a high risk of it. Men were randomly assigned to testosterone gel or a placebo gel and followed for an average of about two years. Testosterone did not increase the rate of heart attack, stroke or cardiovascular death compared with placebo.

The FDA did add something new at the same time: a warning about increases in blood pressure, based on ambulatory blood pressure studies. TRAVERSE also found slightly higher rates of atrial fibrillation, acute kidney injury and pulmonary embolism in the testosterone group. Those findings are why monitoring is still part of every responsible TRT plan.

The boxed warning about secondary exposure to testosterone gel (for example, a partner or child touching treated skin) stayed in place for topical products.

In June 2026, the U.S. Department of Health and Human Services asked the FDA to go further. HHS requested removal of the 2015 label language stating that the safety and effectiveness of testosterone had not been established for men with age-related low testosterone. It also asked the FDA to narrow the prostate-related warnings, citing newer safety data, including TRAVERSE findings on prostate outcomes.

This is a request to the FDA, not a final label. Until the FDA acts, the current label stays in effect. We will update this post when the FDA publishes revised labeling.

What this means for men in their 40s, 50s and 60s

The practical takeaway is that the conversation has shifted from "Is TRT dangerous for my heart?" to "Am I a good candidate, and how will we monitor it?" That is a healthier question.

For men over 40, it means:

  • Heart history is no longer an automatic no. A man with cardiovascular risk factors can have a real discussion about TRT, with his physician weighing his full history.
  • Age-related low T is getting a fresh look. Many men's testosterone declines gradually with age. If HHS's request is adopted, the label will no longer describe that group as unproven.
  • Symptoms still have to match the labs. TRT is for men with consistently low testosterone and symptoms that fit, not for a single borderline result.

What stays the same: labs, blood pressure checks, prostate monitoring

None of the label changes remove the need for good medical oversight. A responsible TRT program still includes:

What is checkedWhy it matters
Total and free testosterone (early morning, repeated)Confirms low levels and guides dosing
Hematocrit and hemoglobin (CBC)Testosterone can raise red blood cell counts
Blood pressureThe FDA added a blood pressure warning in 2025
PSA and prostate historyBaseline and ongoing prostate monitoring
Estradiol, lipids, metabolic panelTracks how the body responds overall

Follow-up labs typically happen a few months after starting and then at regular intervals once a dose is stable.

How Andrologix decides who is a candidate

At Andrologix, TRT starts with a conversation and a full lab panel, not a prescription. Your physician reviews your symptoms, medical history, medications and goals alongside your labs. If testosterone is low and your symptoms fit, your plan covers the type of testosterone, dosing, how often labs are checked and what you should notice over time.

If your labs point somewhere else, such as thyroid, sleep or metabolic issues, we will tell you that too. You can read more about our approach on the HRT for Men page, or book a consultation to get your labs started. Patients in northern Palm Beach County can explore Jupiter-area care.

Coming up in this series: the nine low testosterone symptoms men overlook, and the labs that confirm them.

Frequently asked questions

Is testosterone therapy safe for your heart?

The TRAVERSE trial of 5,246 men with heart disease or high cardiovascular risk found that testosterone did not increase heart attack, stroke or cardiovascular death compared with placebo. Based on that trial, the FDA removed cardiovascular risk language from the boxed warning in 2025. Blood pressure and red blood cell counts still need regular monitoring.

Can I get TRT if my low testosterone is age-related?

Yes, many men with age-related low testosterone are evaluated for TRT when their labs are consistently low and their symptoms fit. In June 2026, HHS asked the FDA to remove label language saying TRT was not established for age-related low testosterone. A physician decides based on your labs, symptoms and history.

What labs do I need before starting TRT?

Expect early-morning total testosterone, usually on two separate days, plus free testosterone, a complete blood count, PSA, estradiol, a metabolic panel and lipids. Some men also need thyroid, LH and FSH testing. These results confirm the diagnosis and give your physician a baseline for safe monitoring.

How soon will I notice results on TRT?

Many men notice changes in energy, mood and sex drive within 3 to 6 weeks. Changes in body composition and strength usually take 3 to 6 months. Everyone responds differently, which is why follow-up labs and check-ins are part of the plan.

Sources

  1. FDA: Class-wide labeling changes for testosterone products (Feb 2025)
  2. HHS: FDA requests updates to testosterone therapy labeling (Jun 2026)
  3. Urology Times: HHS requests testosterone therapy label updates citing new safety data
  4. New England Journal of Medicine: Cardiovascular Safety of Testosterone-Replacement Therapy (TRAVERSE)